Theodora W Salcedo

Title: Theodora W. Salcedo: Innovator in Cancer Treatment

Introduction

Theodora W. Salcedo is a prominent inventor based in Gaithersburg, MD (US), known for her significant contributions to cancer treatment through innovative antibody technologies. With a total of five patents to her name, she has made remarkable strides in the field of medical research, particularly in the treatment of proliferative disorders.

Latest Patents

Her latest patents focus on methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors, specifically TR4. These inventions relate to antibodies and related molecules that have potential applications in the prevention and treatment of cancers and other proliferative disorders. The patents also encompass nucleic acid molecules encoding anti-TR4 antibodies, as well as vectors and host cells containing these nucleic acids. The methods and compositions described in her patents aim to detect, diagnose, treat, or ameliorate diseases, especially cancer and other hyperproliferative disorders, by administering effective amounts of antibodies or their variants that bind to TRAIL receptor TR4.

Career Highlights

Throughout her career, Theodora has worked with notable organizations, including Human Genome Sciences, Inc. and the Beatson Institute for Cancer Research. Her work has been instrumental in advancing the understanding and treatment of cancer, showcasing her dedication to improving patient outcomes through innovative research.

Collaborations

Theodora has collaborated with esteemed colleagues such as Steven M. Ruben and Craig A. Rosen, contributing to a rich exchange of ideas and advancements in cancer research.

Conclusion

Theodora W. Salcedo's innovative work in the field of cancer treatment through antibody technology highlights her role as a leading inventor. Her contributions continue to pave the way for new therapeutic approaches in combating cancer and improving the lives of patients.